drugset / Trial / NCT00913796

Metabolic Acidosis in Renal Transplant Patients

NCT00913796

RandomizedParallel-groupSingle-blindTreatment

Summary

Acidosis (accumulation of acid in the body) may be an underrecognized problem in patients after renal transplantation. It may have consequences on physical performance due to negative effects on bone and muscle metabolism. Therefore, the purpose of this study is 1. to determine the status of physical capacity and bone structure in renal transplant patients with metabolic acidosis 2. to study the effect of substituting base equivalents (citrate) on acid/base status of renal transplant patients with acidosis 3. to compare the status of physical capacity and bone structure in renal transplant patients with metabolic acidosis before and after substitution with citrate

Timeline

Start
2007-12
Primary completion
2010-03
Completion
2010-03

Drugs

EvaluationDrugModalityDoseRoute
Subject POTASSIUM CITRATE ANHYDROUS Small molecule 2.41 g
Comparator Potassium Chloride Small molecule 370 mg